While the fledgling company faces the same challenges as many start-ups, Orizuru has the backing of T-CiRA, a joint research program between pharmaceutical and academic heavyweights, Takeda Pharmaceutical and Kyoto University.

Hear from the CEO of Orizuru Therapeutics, Kenji Nonaka, and the head of T-CiRA Discovery and Innovation, Yasushi Kajii, as they sit down to discuss how Orizuru is progressing, company challenges and successes, and vision for the future.

Click here for the video on YouTube

Learn more about T-CiRA at
https://www.takeda.com/what-we-do/t-cira/